Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: Implications for interindividual differences in nicotine metabolism

Drug Metabolism and Disposition

Volumn 29, Issue 2, 2001, Pages 91-95

  Oscarson, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CARCINOGEN; COUMARIN; CYTOCHROME P450 2A6; NICOTINE; NITROSAMINE;

ASIA; CANCER SUSCEPTIBILITY; DRUG METABOLISM; ENZYME ACTIVATION; ETHNIC DIFFERENCE; EUROPE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; PRIORITY JOURNAL; SHORT SURVEY; SMOKING;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; INDIVIDUALITY; MIXED FUNCTION OXYGENASES; NICOTINE; POLYMORPHISM, GENETIC;

EID: 0035154274     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (48)

1. Individual differences in nicotine kinetics and metabolism in humans
2. CYP2D6 phenotype and the metabolism of nicotine and cotinine
3. Ethnic differences in N-glucuronidation of nicotine and cotinine
4. High variability of nitrosamine metabolism among individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans
5. Metabolism of nicotine by human liver microsomes: Stereoselective formation of trans-nicotine N′-oxide
6. Low frequency of CYF2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method
7. Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine
8. Expression and alternative splicing of the cytochrome P-450 CYP2AT
9. A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles
10. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6
11. A single amino acid substitution (Leul60His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin
12. Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19
13. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment
14. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians
15. Interindividual variability of coumarin 7-hydroxylation in a Turkish population
16. The significance of the homozygous CYP2A6 deletion on nicotine metabolism: A new genotyping method of CYP2A6 using a single PCR-RFLP
17. Expression of CYP2A genes in human liver and extrahepatic tissues
18. Genetic variation of CYP2A6, smoking, and risk of cancer
19. Genetic polymorphisms of cytochrome P450 2A6 in a case control study on lung cancer in a French population
20. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes
21. Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: Implications for the assignment of substrate specificity
22. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity
23. CYP2A6 gene deletion reduces susceptibility to lung cancer
24. Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism
25. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes
26. Role of human cytochrome P4502A6 in C-oxidation of nicotine
27. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502)
28. Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype
29. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
30. Identification and characterisation of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism
31. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
32. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo
33. CYP2A6 a human coumarin 7-hydroxylase
34. Environment and cancer: Who are susceptible?
35. Nicotine metabolism defect reduces smoking
36. Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking
37. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
38. Genetic influences on smoking: Candidate genes
39. An improved assay shows no association between the CYP2A6 gene and cigarette smoking behavior
40. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking
41. Ethnic-related differences in coumarin 7·hydroxylation activities catalyzed by cytochrome P4502A6 in liver micrnsomes of Japanese and Caucasian populations
42. CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coamarin in patients with liver and kidney diseases and epileptic patients
43. Human cytochrome P450 CYP2A13 predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
44. CYP2A6 genotype and smoking
45. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes
46. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes
47. Purification and characterization of human liver microsomal cytochrome P-450 2A6
48. Biotransformation of coumarin by rodent and human cytochromes P450: Metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice